IRD Financials
Opus Genetics Inc - Financial statements & key metrics
Stock Price
$5.71
Market Cap
$396.30M
EPS
$-0.80
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$10.99M
Gross Profit
-
Operating Income
-
Net Income
$-57.53M
EPS (Diluted)
$-2.15
Balance Sheet Highlights
Total Assets
$36.86M
Total Liabilities
$11.29M
Shareholders Equity
-
Cash & Equivalents
$30.32M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-25.58M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
-117.0%
Operating Margin
-3.0%
ROE
-2.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is IRD revenue?
IRD's most recent quarterly revenue was $10.99M. Annual revenue can be calculated by summing the four most recent quarters.
Is IRD profitable?
IRD reported a loss of $57.53M in the most recent quarter.
What is IRD market cap?
IRD has a market capitalization of $396.30M, making it a small-cap stock.
Does IRD have debt?
View IRD's balance sheet for debt information.
What is IRD cash flow?
Cash flow data is available in the full financial statements.